FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress responseToshikatsu Ikeda(Nihon University), Shuichi Hirai(Nihon University)Scientific ReportsJune 7, 202410.1038/s41598-024-64043-2Cited by 7SaveCiteExport RISWatch citationsRelated Papers<scp>SCD1</scp> inhibition enhances the effector functions of <scp>CD8</scp><sup>+</sup> T cells via <scp>ACAT1</scp>‐dependent reduction of esterified cholesterol|Cancer Science|2023|29